MeiraGTx Holdings plc
NASDAQ:MGTXBiotechnology
Healthcare
$8.32 +5.08%
+$0.53 today
- Market cap
- $813.12M
- Beta
- 1.26
- P/E (TTM)
- -7.4
- EPS (TTM)
- -$1.48
52W Low $6.07High $11.85
Volume 0.58M
Average 0.84M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$46.36M
FY 2025 · Annual
Investing Cash Flow
-$4.11M
FY 2025 · Annual
Financing Cash Flow
$12.27M
FY 2025 · Annual
-77.5% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Depreciation & Amortization | 7.87M | 8.6M | 13.72M | 12.68M | 12.7M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 20.78M | 28.62M | 27.72M | 25.19M | 22.11M |
| Change in Working Capital | 31.28M | 9.62M | (983K) | 29.64M | 28.03M |
| Accounts Receivables | 16.7M | 5.17M | 4.83M | 9.43M | (7.27M) |
| Inventory | 0 | 0 | 0 | (387K) | 428K |
| Accounts Payables | 13.35M | 3.74M | 2.33M | 10.74M | (12.31M) |
| Other Working Capital | 1.23M | 713K | (8.14M) | 9.87M | 47.18M |
| Other Non-Cash Items | 9.1M | 9.67M | (61.8M) | (24.22M) | 5.01M |
| Operating Cash Flow | (10.53M) | (73.1M) | (105.37M) | (104.5M) | (46.36M) |
| Capital Expenditures | (55.22M) | (44.96M) | (20.17M) | (4.96M) | (3.83M) |
| Acquisitions (Net) | (6.5M) | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 54.21M | 28.43M | (281K) |
| Investing Cash Flow | (61.72M) | (44.96M) | 34.03M | 23.48M | (4.11M) |
| Debt Repayment | (1K) | 75M | 0 | 0 | (29K) |
| Common Stock Issued | 1.71M | 25M | 91.95M | 59.39M | 15.33M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (4.8M) | (7.93M) | (4.86M) | (3.03M) |
| Financing Cash Flow | 1.71M | 95.2M | 84.02M | 54.53M | 12.27M |
| Effect of Forex Changes | (1.28M) | 674K | 2.44M | 1.5M | 719K |
| Net Change in Cash | (71.82M) | (22.19M) | 15.13M | (24.98M) | (37.48M) |
| Free Cash Flow | (65.75M) | (118.06M) | (125.54M) | (109.45M) | (50.19M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$114.2M
+ D&A$12.7M
+ Stock-Based Comp$22.1M
+ Deferred Tax$0
+ Working Capital$28.0M
+ Other Non-Cash$5.0M
= Operating Cash Flow-$46.4M
- Capex-$3.8M
= Free Cash Flow-$50.2M
Analysis
FY2025 free cash flow is -$50.2M. FCF conversion is 43.9% of net income. Operating cash flow was -$46.4M, with capex of -$3.8M. The largest bridge item is Working Capital at $28.0M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 12, 2026 | |
| S-3ASR | S-3ASR filing | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 20, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 6, 2026 |
Does MGTX generate free cash flow?
MeiraGTx Holdings plc (MGTX) generated -$50.19M of free cash flow in fiscal 2025.
How much operating cash flow does MGTX produce?
Operating cash flow was -$46.36M, before capital expenditures of $3.83M.
Continue the stock analysis
Jump to another research area for this company.